Theseus Pharmaceuticals lays off most workers and seeks 'strategic alternatives' after cancer pipeline failure
Theseus Pharmaceuticals said after Monday’s closing bell that it will let go of 72% of its workforce, or about 26 people, and will seek “strategic …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
